Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease von willebrand disease
Comorbidity C0010068|coronary heart disease
Sentences 2
PubMedID- 23408959 We aimed to assess associations of circulating tissue plasminogen activator (t-pa) antigen, d-dimer and von willebrand factor (vwf) with coronary heart disease risk.
PubMedID- 24431031 Other independent studies demonstrated a beneficial effect of the c34t mutation on metabolic aspects related to the cardiovascular system such as a lower level of an inhibitor of plasminogen activator and soluble von willebrand factor in patients with coronary heart disease [8].

Page: 1